Marie Georges Beauchamps

This inventor holds 13 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Signal Pharmaceuticals, Inc., Celgene Corporation. Active years: 2012-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marie Georges Beauchamps. Retrieved from https://idiyas.com/inventor/marie-georges-beauchamps

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 4)

% Patents Active = 84.6

CIPO Patents = 3

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 7.7

ph-index = 4

Forward Citations = 82(Granted Patents)

Location History:

Flander, NJ (US) (2012)
Madison, NJ (US) (2013 - 2017)
Randolph, NJ (US) (2016 - 2022)

Company Filing History:

11 out of 169

Signal Pharmaceuticals, Inc.

Years Active: 2012-2022

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11312699 - Processes for preparing 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide (2022-04-26),

2. 11241430 - Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use (2022-02-08),

3. 10604510 - Solid forms comprising (1E, 4E)-2-amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo[B]azepine-4-carboxami compositions thereof, and uses thereof (2020-03-31),

4. 10517873 - Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use (2019-12-31),

5. 10226461 - Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use (2019-03-12),

6. 9974786 - [object Object] (2018-05-22),

7. 9814713 - Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use (2017-11-14),

8. 9795603 - Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use (2017-10-24),

9. 9604939 - Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-YL)pyridin-3-YL)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use (2017-03-28),

10. 9365524 - Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use (2016-06-14),

11. 9079900 - Methods of synthesis and purification of heteroaryl compounds (2015-07-14),

12. 8569494 - Methods of synthesis and purification of heteroaryl compounds (2013-10-29),

13. 8158635 - [object Object] (2012-04-17),

Title: The Innovative Contributions of Marie Georges Beauchamps

Introduction

Marie Georges Beauchamps is a distinguished inventor based in Randolph, NJ, with an impressive portfolio that includes 13 patents. Her innovative work primarily focuses on advanced chemical processes and formulations, which have significant implications in various fields, including pharmaceuticals.

Latest Patents

Among her latest patents, one notable invention pertains to the "Processes for preparing 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide." This patent outlines comprehensive processes that enable the efficient synthesis of this compound. Additionally, she has developed solid forms and related compositions concerning "2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide," which includes formulation methods and applications.

Career Highlights

Marie has had a prominent career, having worked for reputable companies such as Signal Pharmaceuticals and Celgene Corporation. Her contributions to these organizations have not only propelled her career but also fostered the development of innovative solutions in the pharmaceutical industry.

Collaborations

Throughout her career, Marie Georges Beauchamps has collaborated with talented individuals, including Mohit Atul Kothare and Hon-Wah Man. These collaborations have been instrumental in enhancing her research capabilities and expanding her inventive horizons.

Conclusion

Marie Georges Beauchamps exemplifies excellence in innovation and invention, with a significant impact on the fields of chemistry and pharmaceuticals. Her extensive portfolio and collaborative efforts with leading professionals underscore her dedication to advancing scientific knowledge and practical applications. As she continues to develop new technologies and solutions, the future looks promising for her contributions to the industry.

Profile summary based on public USPTO records.